°£¼¼Æ÷¾ÏÁ¾ÀÇ °íÁÖÆÄ ¿Ä¡·á¼ú
Radiofrequency Ablation for Hepatocellular Carcinoma
Journal of Liver Cancer 2015³â 15±Ç 2È£ p.79 ~ p.83
Àå¼¼¿µ:Jang Se-Yong
¹Ú¼ö¿µ:Park Soo-Young
Abstract
Radiofrequency ablation (RFA) takes an important role in management of hepatocellular carcinoma (HCC) as the most popular local therapy in the world. There are many data supporting that RFA is an excellent treatment modality for early-stage HCC with favorable treatment outcomes and minimal invasiveness. Currently, RFA extends treatement indications from unresectable early-stage HCC to intermediate-stage HCC in selected cases. Thus, with technical advances in guidance and ablation as well as devices, RFA widens its territory in the combat field against HCC.
Å°¿öµå
Ablation, Hepatocellular carcinoma, Ultrasonography
KMID :
1039320150150020079
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
°íÁÖÆÄ ¿Ä¡·á¼úÀº Ãʱ⠰£¼¼Æ÷¾ÏÁ¾¿¡ ´ëÇÑ Ä¡·á ¼ºÀûÀÌ ¿ì¼öÇÏ°í ½Ã¼ú¿¡ ´ëÇÑ À§ÇèÀº Àû¾î ¼ö¼úÀû ÀýÁ¦°¡ ºÒ°¡´É ÇÑ Ãʱ⠰£¼¼Æ÷¾ÏÁ¾ÀÇ ±ÙÄ¡Àû Ä¡·á·Î ³Î¸® ÀÌ¿ëµÇ°í ÀÖ´Ù.